India's Pharmaceutical Exports

Country Profile

Maldives

Maldives is an emerging destination for Indian pharmaceutical exports — $33.8M in FY 2025–26, with 3.1× growth over the past decade. Medicines accounts for 83% of shipments, with vaccines contributing $1.65M. The compound annual growth rate since FY2015 stands at 10.7%.

🇲🇻 $33.8M · 3.1× growth since FY2015 · 10.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$33.8M
Exports FY2025–26 DGCIS
3.1×
Growth FY2015→2026
10.7%
CAGR FY2015→2026
83%
Medicines Share
4
Product Categories Supplied
Maldives is an emerging destination for Indian pharmaceutical exports — $33.8M in FY 2025–26, with 3.1× growth over the past decade. Medicines accounts for 83% of shipments, with vaccines contributing $1.65M. The compound annual growth rate since FY2015 stands at 10.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $27.9M (82.7%) Surgical & Hospital Supplies $3.91M (11.6%) Vaccines $1.65M (4.9%) Traditional & Herbal $289K (0.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Maldives in the RBI overseas direct investment dataset (2011–2026).